Veeva Systems (VEEV) Upgraded At Morgan Stanley

NEW YORK (TheStreet) -- Veeva Systems Inc.  (VEEV) has been upgraded to "overweight" from "equalweight" at Morgan Stanley at a set price target of $40.

"Veeva is a TAM expansion story in our view," Morgan Stanley said. "And the company is executing on that front with early success in both vault and network...We believe some investors are overlooking the opportunity for Veeva to become the leading IT cloud for Life Sciences, beyond just SFA."

"We think the stock now undervalues the long term growth potential of the business, and we are upgrading to "overweight"...we expect increasing positive data around new products, sales to drive shares higher over time for those willing to ride out the noise, while Veeva's growth and margin profile remains among the best in SaaS," the firm added.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

 VEEV ChartVEEV data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

 

If you liked this article you might like

10 Favorite Healthcare Stocks for 2018: Medical Marijuana to Opioid Treatment

10 Favorite Healthcare Stocks for 2018: Medical Marijuana to Opioid Treatment

GLD Trade Has Lost Its Shine

GLD Trade Has Lost Its Shine

Viva La Veeva Volatility

Viva La Veeva Volatility

'Cloud Wars' Intensify; Staples Shows Some Staying Power -- ICYMI Friday

'Cloud Wars' Intensify; Staples Shows Some Staying Power -- ICYMI Friday

Cloud Software Is Booming -- Just Ask Workday and Salesforce

Cloud Software Is Booming -- Just Ask Workday and Salesforce